Hanall Biopharma Revenue

Hanall Biopharma had revenue of 40.80B KRW in the quarter ending September 30, 2025, with 10.76% growth. This brings the company's revenue in the last twelve months to 154.05B, up 14.76% year-over-year. In the year 2024, Hanall Biopharma had annual revenue of 138.94B with 2.99% growth.

Revenue (ttm)

154.05B

Revenue Growth

+14.76%

P/S Ratio

15.27

Revenue / Employee

506.75M

Employees

304

Market Cap

2.35T

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	138.94B	4.03B	2.99%
Dec 31, 2023	134.91B	24.91B	22.65%
Dec 31, 2022	110.00B	8.40B	8.27%
Dec 31, 2021	101.59B	12.99B	14.66%
Dec 31, 2020	88.60B	-19.85B	-18.30%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	5.50T
Celltrion	3.90T
Yuhan	2.17T
Hanmi Pharm.	1.50T
SK Biopharmaceuticals	675.41B
Sam Chun Dang Pharm.	215.10B
ALTEOGEN	158.06B
LigaChem Biosciences	148.28B

Revenue Rankings